Skip to main content

Skip to Content

Newcastle Magnetic Resonance Centre

Oncology

Oncology Research

Newcastle University was awarded a Cancer Imaging Programme by the CRUK/EPSRC/MRC funding call.

Clinical studies arising from the Imaging Programme and from collaborations with the Northern Institute for Cancer Research are performed at the Centre.

Members of the Centre are involved in developing pre-clinical contrast media for work on our small bore MRI system.

Oncology projects

A cancer research UK phase I trial of AZD3965, a monocarboxylate transporter 1 inhibitor (MCT1) in patients with advanced cancer (Non-Hodgkins Lymphoma. MCT1 Inhibitor study)
Project Leader(s): Professor Ruth Plummer

Publications

Zahra MA, Hollingsworth KG, Sala E, Lomas DJ, Tan LT. Dynamic contrast-enhanced MRI as a predictor of tumour response to radiotherapy. Lancet Oncology 2007; 8(1), 63-74.